Xylem XYL Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $978M+2.5% | $954M+0.7% | $947M+1.0% | $938M+3.5% | $906M+1.8% | ||
| $264M-1.1% | $267M-0.4% | $268M-1.5% | $272M+2.6% | $265M+2.7% | ||
| $54M+1.9% | $53M+6.0% | $50M0.0% | $50M0.0% | $50M-10.7% | ||
| —— | -$35M+0.7% | -$35.25M+0.7% | -$35.5M+0.7% | -$35.75M+0.7% | ||
| $113M+9.7% | $103M+8.4% | $95M+25.0% | $76M+4.1% | $73M+17.7% | ||
| —— | —— | -$87M-67.3% | -$52M-2.0% | -$51M-10.9% | ||
| -$14M+39.1% | -$23M— | —— | —— | —— | ||
| —— | —— | $50M-30.6% | $72M+1,300% | -$6M-109% | ||
| —— | -$69M-45.3% | -$47.5M-82.7% | -$26M-478% | -$4.5M-126% | ||
| $177M+177% | $64M+156% | -$115M-38.6% | -$83M-493% | -$14M-164% | ||
| —— | $0-100% | $38M-50.0% | $76M-33.3% | $114M-25.0% | ||
| —— | —— | $119M-5.6% | $126M+16.7% | $108M+0.9% | ||
| —— | $26M+1.0% | $25.75M+1.0% | $25.5M+1.0% | $25.25M+1.0% | ||
| $1.32B+6.0% | $1.24B-2.5% | $1.27B+4.0% | $1.22B+1.4% | $1.21B-4.4% | ||
| $350M+5.7% | $331M-4.9% | $348M+1.5% | $343M+7.9% | $318M-0.9% | ||
| $156M-4.3% | $163M-45.8% | $301M+54.4% | $195M-2.5% | $200M+3.6% | ||
| $48M-2.0% | $49M+40.0% | $35M+250% | $10M-37.5% | $16M-5.9% | ||
| $3M-94.1% | $51M-3.3% | $52.75M-5.0% | $55.5M-1.3% | $56.25M+192% | ||
| -$1M— | $0-100% | $1M-50.0% | $2M0.0% | $2M+100% | ||
| $13M-23.5% | $17M+6.3% | $16M+167% | $6M-25.0% | $8M+100% | ||
| -$532M-13.0% | -$471M+23.8% | -$618M-25.1% | -$494M-10.8% | -$446M+7.5% | ||
| $399M+2.0% | $391M+2.9% | $380M+2.4% | $371M+3.1% | $360M+2.9% | ||
| $565M+3,667% | $15M0.0% | $15M0.0% | $15M-16.7% | $18M-10.0% | ||
| -$1M— | $0-100% | $2M-60.0% | $5M+150% | $2M+100% | ||
| $82M0.0% | $82M+28.1% | $64M+77.8% | $36M+125% | $16M-5.9% | ||
| $14M-30.0% | $20M+66.7% | $12M0.0% | $12M-70.0% | $40M-40.3% | ||
| -$36M-5.9% | -$34M-6.3% | -$32M+8.6% | -$35M-20.7% | -$29M-3.6% | ||
| -$1.07B-113% | -$501M-5.0% | -$477M-8.4% | -$440M+32.2% | -$649M-5.5% | ||
| $51M-44.0% | $91M+153% | $36M— | —— | —— | ||
| -$251M-170% | $358M+77.2% | $202M-43.1% | $355M+217% | $112M+9.8% | ||
| $60M-1.6% | $61M0.0% | $61M-3.2% | $63M-4.5% | $66M-1.5% | ||
| $258M-3.4% | $267M0.0% | $267M-6.0% | $284M+30.9% | $217M-0.9% | ||
| $306M-0.6% | $308M+0.7% | $306M+1.7% | $301M-2.3% | $308M+1.3% | ||
| $264M-1.1% | $267M-0.4% | $268M-1.5% | $272M+2.6% | $265M+2.7% | ||
| —— | —— | -$87M-67.3% | -$52M-2.0% | -$51M-10.9% | ||
| —— | —— | —— | —— | $59.75M+61.5% | ||
| —— | —— | —— | —— | -$17M-325% | ||
| —— | $26M+1.0% | $25.75M+1.0% | $25.5M+1.0% | $25.25M+1.0% | ||
| $113M+9.7% | $103M+8.4% | $95M+25.0% | $76M+4.1% | $73M+17.7% | ||
| —— | —— | —— | —— | —— | ||
| —— | $37M+33.3% | $27.75M+50.0% | $18.5M+100% | $9.25M— | ||
| -$1M— | $0-100% | $1M-50.0% | $2M0.0% | $2M+100% | ||
| $37M+5.7% | $35M0.0% | $35M-2.8% | $36M+20.0% | $30M+3.4% | ||
| —— | —— | —— | —— | —— | ||
| $13M-23.5% | $17M+6.3% | $16M+167% | $6M-25.0% | $8M+100% | ||
| —— | $0-100% | $250K-50.0% | $500K-33.3% | $750K-25.0% | ||
| -$36M-5.9% | -$34M-6.3% | -$32M+8.6% | -$35M-20.7% | -$29M-3.6% | ||
| —— | —— | —— | $4M+300% | $1M— | ||
| -$17M-1,600% | -$1M+90.9% | -$11M— | $0— | $0+100% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $258M-3.4% | $267M0.0% | $267M-6.0% | $284M+30.9% | $217M-0.9% | ||
| $966M+6.2% | $910M-1.6% | $925M+5.0% | $881M-0.9% | $889M-5.6% | ||
| $966M+6.2% | $910M-1.6% | $925M+5.0% | $881M-0.9% | $889M-5.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Xylem generate?
- Xylem (XYL) generated $1.3B in operating cash flow over the trailing twelve months.
- What is Xylem's free cash flow?
- After $350.0M of capital expenditures, Xylem's free cash flow was $966.0M over the trailing twelve months, up 8.7% year over year.
- Where does Xylem's cash flow data come from?
- Every line is extracted from Xylem's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
